KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to 0.4.

  • Merck's Equity Ratio rose 568.49% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year increase of 568.49%. This contributed to the annual value of 0.4 for FY2024, which is 1223.99% up from last year.
  • Per Merck's latest filing, its Equity Ratio stood at 0.4 for Q3 2025, which was up 568.49% from 0.42 recorded in Q2 2025.
  • Merck's 5-year Equity Ratio high stood at 0.44 for Q1 2023, and its period low was 0.3 during Q1 2021.
  • Its 5-year average for Equity Ratio is 0.39, with a median of 0.39 in 2023.
  • As far as peak fluctuations go, Merck's Equity Ratio skyrocketed by 3049.6% in 2021, and later tumbled by 1638.43% in 2023.
  • Quarter analysis of 5 years shows Merck's Equity Ratio stood at 0.36 in 2021, then grew by 16.57% to 0.42 in 2022, then dropped by 16.38% to 0.35 in 2023, then increased by 12.24% to 0.4 in 2024, then rose by 1.19% to 0.4 in 2025.
  • Its Equity Ratio stands at 0.4 for Q3 2025, versus 0.42 for Q2 2025 and 0.42 for Q1 2025.